Evidence map›Paper›PMID 38003429›Full record

ArticleInternational journal of molecular sciences2023

GSK2656157, a PERK Inhibitor, Alleviates Pyroptosis of Macrophages Induced by Mycobacterium

Boli Ma, Xueyi Nie, Lei Liu, Mengyuan Li, Qi Chen, Yueyang Liu, Yuxin Hou, Yi Yang, Jinrui Xu

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Serine metabolism in macrophage polarization.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Boli MaSchool of Life Sciences, Ningxia University, Yinchuan 750021, China.
Xueyi NieSchool of Life Sciences, Ningxia University, Yinchuan 750021, China.
Lei LiuSchool of Life Sciences, Ningxia University, Yinchuan 750021, China.
Mengyuan LiSchool of Life Sciences, Ningxia University, Yinchuan 750021, China.
Qi ChenSchool of Life Sciences, Ningxia University, Yinchuan 750021, China.
Yueyang LiuSchool of Life Sciences, Ningxia University, Yinchuan 750021, China.
Yuxin HouSchool of Life Sciences, Ningxia University, Yinchuan 750021, China.
Yi YangSchool of Life Sciences, Ningxia University, Yinchuan 750021, China.ORCID 0000-0002-6317-5460
Jinrui XuSchool of Life Sciences, Ningxia University, Yinchuan 750021, China.ORCID 0000-0002-9258-8002
Ningxia University · CN

Funding

Natural Science Foundation of Ningxia 2023AAC03100Natural Science Foundation of Ningxia 2023AAC0320
6 · The paper itself

Abstract

Tuberculosis (TB) is the leading cause of human death worldwide due to

Indexed as

Interleukin-18Mycobacterium bovisAdenineAnimalsBCG VaccineCaspase 1CaspasesHumansIndolesMacrophagesMiceMice, Inbred C57BLPyroptosisAdenineBCG VaccineCaspase 1CaspasesGSK2656157IndolesInterleukin-18Bacillus Calmette–GuerinmacrophagesPERKpyroptosis

Identifiers

PMID38003429
PMCPMC10671627
OpenAlexW4388635213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.